Johns Hopkins ABX Guide
Rimantadine
INDICATIONS
FDA
FDA
- Influenza A (prophylaxis and treatment)
- No longer recommended as influenza strains circulating are resistant since the 2008-2009 respiratory season.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 18, 2022
Citation
Dzintars, Kathryn, and Paul G Auwaerter. "Rimantadine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/0/Rimantadine.
Dzintars K, Auwaerter PG. Rimantadine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/0/Rimantadine. Accessed October 4, 2023.
Dzintars, K., & Auwaerter, P. G. (2022). Rimantadine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/0/Rimantadine
Dzintars K, Auwaerter PG. Rimantadine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2023 October 04]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/0/Rimantadine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rimantadine
ID - 540486
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Auwaerter,Paul,M.D.
Y1 - 2022/10/18/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540486/0/Rimantadine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
